Contact

All Stories

  1. The emergence of RAS mutations in patients with RAS wild-type mCRC receiving cetuximab as first-line treatment: a noninterventional, uncontrolled multicenter study

    Article • British Journal of Cancer, July 2023, Springer Science + Business Media

    Professor Jaw Yuan Wang

  2. Efficacy and Safety of a Parenteral Nutrition Program for Patients with RAS Wild-Type Metastatic Colorectal Cancer Administered First-Line Cetuximab Plus Chemotherapy: A Propensity Score Matching Study

    Article • Nutrients, June 2023, MDPI AG

    Professor Jaw Yuan Wang

  3. Performance of the Fecal Immunochemical Test in Detecting Advanced Colorectal Neoplasms and Colorectal Cancers in People Aged 40–49 Years: A Systematic Review and Meta-Analysis

    Article • Cancers, May 2023, MDPI AG

    Professor Jaw Yuan Wang

  4. Identifying and clinically validating biomarkers for immunotherapy in colorectal cancer

    Article • Expert Review of Molecular Diagnostics, March 2023, Taylor & Francis

    Professor Jaw Yuan Wang

  5. A phase Ib/II trial of PEP503 (NBTXR3, radioenhancer) with radiotherapy and chemotherapy in patients with rectal cancer

    Article • Nanomedicine, March 2023, Future Medicine

    Professor Jaw Yuan Wang

  6. MicroRNAs as Predictive Biomarkers in Patients with Colorectal Cancer Receiving Chemotherapy or Chemoradiotherapy: A Narrative Literature Review

    Article • Cancers, February 2023, MDPI AG

    Professor Jaw Yuan Wang

  7. The Auxiliary Effects of Low-Molecular-Weight Fucoidan in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy Before Surgery: A Double-Blind, Randomized, Placebo-Controlled Study

    Article • Integrative Cancer Therapies, January 2023, SAGE Publications

    Professor Jaw Yuan Wang

  8. Comprehensive Review of Biomarkers for the Treatment of Locally Advanced Colon Cancer

    Article • Cells, November 2022, MDPI AG

    Professor Jaw Yuan Wang

  9. ERCC1 Overexpression Increases Radioresistance in Colorectal Cancer Cells

    Article • Cancers, September 2022, MDPI AG

    Professor Jaw Yuan Wang

  10. Clinical Safety and Effectiveness of Robotic-Assisted Surgery in Patients with Rectal Cancer: Real-World Experience over 8 Years of Multiple Institutions with High-Volume Robotic-Assisted Surgery

    Article • Cancers, August 2022, MDPI AG

    Professor Jaw Yuan Wang

  11. Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer: Where Are We at?

    Article • Cancers, June 2022, MDPI AG

    Professor Jaw Yuan Wang

  12. Metformin Enhancement of Therapeutic Effects of 5-Fluorouracil and Oxaliplatin in Colon Cancer Cells and Nude Mice

    Article • Biomedicines, April 2022, MDPI AG

    Professor Jaw Yuan Wang

  13. Comparison of Next-Generation Sequencing and Polymerase Chain Reaction for Personalized Treatment-Related Genomic Status in Patients with Metastatic Colorectal Cancer

    Article • Current Issues in Molecular Biology, April 2022, MDPI AG

    Professor Jaw Yuan Wang

  14. Clinical Outcomes of Patients with Peritoneal Metastasis-Only Colorectal Cancer Treated with First-Line Bevacizumab and FOLFIRI Through Irinotecan Dose Escalation According to UGT1A1 Polymorphism: Compared to Liver Metastasis-Only, and Lung Metastasis-...

    Article • Cancer Management and Research, April 2022, Taylor & Francis

    Professor Jaw Yuan Wang

  15. Genomic and Metabolomic Landscape of Right-Sided and Left-Sided Colorectal Cancer: Potential Preventive Biomarkers

    Article • Cells, February 2022, MDPI AG

    Professor Jaw Yuan Wang

  16. The Evolving Landscape, Clinical Implications and Future Perspective of Biomarkers in Gastrointestinal Cancers

    Article • January 2022, Frontiers

    Professor Jaw Yuan Wang

  17. Safety of cold snare polypectomy with periprocedural antithrombotic agents for colorectal polyps: a systematic review and meta-analysis

    Article • Therapeutic Advances in Gastroenterology, January 2022, SAGE Publications

    Professor Jaw Yuan Wang

  18. BRAF, MEK, and EGFR Triplet Inhibitors as Salvage Therapy in BRAF-Mutated Metastatic Colorectal Cancer—A Case Series Study Target Therapy of BRAF-Mutated mCRC

    Article • Medicina, December 2021, MDPI AG

    Professor Jaw Yuan Wang

  19. Critical reappraisal of neoadjuvant concurrent chemoradiotherapy for treatment of locally advanced colon cancer

    Article • PLoS ONE, November 2021, PLOS

    Professor Jaw Yuan Wang

  20. miRNA-148a Enhances the Treatment Response of Patients with Rectal Cancer to Chemoradiation and Promotes Apoptosis by Directly Targeting c-Met

    Article • Biomedicines, October 2021, MDPI AG

    Professor Jaw Yuan Wang

  21. Low-Molecular-Weight Fucoidan as Complementary Therapy of Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer

    Article • International Journal of Molecular Sciences, July 2021, MDPI AG

    Professor Jaw Yuan Wang

  22. Oncological Outcomes of Patients with Peritoneal Metastasis–only Colorectal Cancer Treated with First-line Bevacizumab and FOLFIRI through Irinotecan Dose Escalation According to UGT1A1 Polymorphism: Compared to Liver Metastasis–only, and Lung Metastas...

    Article • July 2021, Research Square

    Professor Jaw Yuan Wang

  23. Narrative review of the influence of diabetes mellitus and hyperglycemia on colorectal cancer risk and oncological outcomes

    Article • Translational Oncology, July 2021, Elsevier

    Professor Jaw Yuan Wang

  24. Low-Molecular-Weight Fucoidan as Complementary Therapy of Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer

    Article • June 2021, MDPI AG

    Professor Jaw Yuan Wang

  25. Correlations between Urinary Monoethylhexyl Phthalate Concentration in Healthy Individuals, Individuals with Colorectal Adenomas, and Individuals with Colorectal Cancer

    Article • Journal of Agricultural and Food Chemistry, June 2021, American Chemical Society (ACS)

    Professor Jaw Yuan Wang

  26. Time interval between the completion of radiotherapy and robotic-assisted surgery among patients with stage I–III rectal cancer undergoing preoperative chemoradiotherapy

    Article • PLoS ONE, October 2020, PLOS

    Professor Jaw Yuan Wang

  27. Transcatheter arterial embolization as an effective treatment for spontaneous inferior epigastric artery bleeding caused by anticoagulant therapy: Case reports

    Article • World Academy of Sciences Journal, September 2020, Spandidos Publications

    Professor Jaw Yuan Wang

  28. ERCC overexpression associated with a poor response of cT4b colorectal cancer with FOLFOX‑based neoadjuvant concurrent chemoradiation

    Article • Oncology Letters, September 2020, Spandidos Publications

    Professor Jaw Yuan Wang

  29. Observational Study Comparing Efficacy and Safety between Neoadjuvant Concurrent Chemoradiotherapy and Chemotherapy for Patients with Unresectable Locally Advanced or Metastatic Gastric Cancer

    Article • Journal of Oncology, September 2020, Hindawi Publishing Corporation

    Professor Jaw Yuan Wang

  30. Effects of Good Pain Management (GPM) ward program on patterns of care and pain control in patients with cancer pain in Taiwan

    Article • Supportive Care in Cancer, August 2020, Springer Science + Business Media

    Professor Jaw Yuan Wang

  31. Unusual Pediatric Sigmoid Perivascular Epithelioid Cell Tumor with Regional Lymph Node Metastasis Treated Using Gemcitabine and Docetaxel: A Case Report and Literature Review

    Article • August 2020, Research Square

    Professor Jaw Yuan Wang

  32. Smartband use during enhanced recovery after surgery facilitates inpatient recuperation following minimally invasive colorectal surgery

    Article • August 2020, Research Square

    Professor Jaw Yuan Wang

  33. Smartband use during enhanced recovery after surgery facilitates inpatient recuperation following minimally invasive colorectal surgery

    Article • June 2020, Research Square

    Professor Jaw Yuan Wang

  34. Smartband use during enhanced recovery after surgery facilitates inpatient recuperation following minimally invasive colorectal surgery

    Article • May 2020, Research Square

    Professor Jaw Yuan Wang

  35. Machine Learning for Predicting Pathological Complete Response in Patients with Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy

    Article • April 2020, Research Square

    Professor Jaw Yuan Wang

  36. Observational Study Comparing Efficacy and Safety Between Preoperative Neoadjuvant Concurrent Chemoradiotherapy and Chemotherapy for Patients with Unresectable Locally Advanced or Metastatic Gastric Cancer

    Article • February 2020, Research Square

    Professor Jaw Yuan Wang

  37. An observational study of patho-oncological outcomes of various surgical methods in total mesorectal excision for rectal cancer: a single center analysis

    Article • BMC Surgery, February 2020, Springer Science + Business Media

    Professor Jaw Yuan Wang

  38. Predictive Value of FOLFOX-Based Regimen, Long Interval, Hemoglobin Levels and Clinical Negative Nodal Status, and Postchemoradiotherapy CEA Levels for Pathological Complete Response in Patients with Locally Advanced Rectal Cancer after Neoadjuvant Che...

    Article • Journal of Oncology, January 2020, Hindawi Publishing Corporation

    Professor Jaw Yuan Wang

  39. An observational study of patho-oncological outcomes of various surgical methods in total mesorectal excision for rectal cancer: a single center analysis

    Article • January 2020, Research Square

    Professor Jaw Yuan Wang

  40. Observational Study Comparing Efficacy and Safety Between Preoperative Neoadjuvant Concurrent Chemoradiotherapy and Chemotherapy for Patients with Unresectable Locally Advanced or Metastatic Gastric Cancer

    Article • December 2019, Research Square

    Professor Jaw Yuan Wang

  41. Surgical treatment following neoadjuvant chemoradiotherapy in locally advanced rectal cancer

    Article • The Kaohsiung Journal of Medical Sciences, December 2019, Wiley

    Professor Jaw Yuan Wang

  42. Impact of a Dual-Ring Wound Protector on Outcome After Elective Surgery for Colorectal Cancer

    Article • Journal of Surgical Research, December 2019, Elsevier

    Professor Jaw Yuan Wang

  43. Regorafenib plus FOLFIRI with irinotecan dose escalated according to uridine diphosphate glucuronosyltransferase 1A1genotyping in previous treated metastatic colorectal cancer patients:study protocol for a randomized controlled trial

    Article • Trials, December 2019, Springer Science + Business Media

    Professor Jaw Yuan Wang

  44. Regorafenib plus FOLFIRI with irinotecan dose escalated according to uridine diphosphate glucuronosyltransferase 1A1 genotyping in previous treated metastatic colorectal cancer patients: study protocol for a randomized controlled trial

    Article • November 2019, Research Square

    Professor Jaw Yuan Wang

  45. An observational study of Patho-oncological outcomes of various surgical methods in rectal cancer: a single center analysis

    Article • November 2019, Research Square

    Professor Jaw Yuan Wang

  46. Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: a study protocol

    Article • BMC Cancer, June 2019, Springer Science + Business Media

    Professor Jaw Yuan Wang

  47. Functional Effects of let-7g Expression in Colon Cancer Metastasis

    Article • Cancers, April 2019, MDPI AG

    Professor Jaw Yuan Wang

  48. miR‐148a inhibits early relapsed colorectal cancers and the secretion of VEGF by indirectly targeting HIF‐1α under non‐hypoxia/hypoxia conditions

    Article • Journal of Cellular and Molecular Medicine, March 2019, Wiley

    Professor Jaw Yuan Wang

  49. Cost-effectiveness of mini-laparotomy in patients with colorectal cancers: A propensity scoring matching approach

    Article • PLoS ONE, January 2019, PLOS

    Professor Jaw Yuan Wang

  50. Interaction between Tumor-Associated Dendritic Cells and Colon Cancer Cells Contributes to Tumor Progression via CXCL1

    Article • International Journal of Molecular Sciences, August 2018, MDPI AG

    Professor Jaw Yuan Wang

  51. Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer

    Article • Radiation Oncology, March 2018, Springer Science + Business Media

    Professor Jaw Yuan Wang

  52. Combination of arginine, glutamine, and omega-3 fatty acid supplements for perioperative enteral nutrition in surgical patients with gastric adenocarcinoma or gastrointestinal stromal tumor (GIST): A prospective, randomized, double-blind study

    Article • Journal of Postgraduate Medicine, January 2018, Medknow

    Professor Jaw Yuan Wang

  53. Safe Bowel Anastomosis in Minimal Invasive Surgery for Colorectal Cancer

    Article • January 2018, Springer Science + Business Media

    Professor Jaw Yuan Wang

  54. First-decade patient with colorectal cancer carrying both germline and somatic mutations in APC gene

    Article • BMC Cancer, December 2017, Springer Science + Business Media

    Professor Jaw Yuan Wang

  55. Robotic-assisted total mesorectal excision with the single-docking technique for patients with rectal cancer

    Article • BMC Surgery, December 2017, Springer Science + Business Media

    Professor Jaw Yuan Wang

  56. Neoadjuvant FOLFOX chemotherapy combined with radiotherapy followed by radical resection in patients with locally advanced colon cancer

    Article • Radiation Oncology, March 2017, Springer Science + Business Media

    Professor Jaw Yuan Wang

  57. The impact of complications on prolonged length of hospital stay after resection in colorectal cancer: A retrospective study of Taiwanese patients

    Article • Journal of International Medical Research, February 2017, SAGE Publications

    Professor Jaw Yuan Wang

  58. An observational study of extending FOLFOX chemotherapy, lengthening the interval between radiotherapy and surgery, and enhancing pathological complete response rates in rectal cancer patients following preoperative chemoradiotherapy

    Article • Therapeutic Advances in Gastroenterology, July 2016, SAGE Publications

    Professor Jaw Yuan Wang

  59. FOLFIRI and regorafenib combination therapy with dose escalation of irinotecan as fourth-line treatment for patients with metastatic colon cancer according to UGT1A1 genotyping

    Article • OncoTargets and Therapy, November 2014, Taylor & Francis

    Professor Jaw Yuan Wang

  60. Co‐existence of cyclin D1 and vascular endothelial growth factor protein expression is a poor prognostic factor for UICC stage I–III colorectal cancer patients after curative resection

    Article • Journal of Surgical Oncology, August 2012, Wiley

    Professor Jaw Yuan Wang